Starlose is a pharmaceutical co-processed excipient composed of maize starch and lactose monohydrate.

Starlose is designed for use in oral solid dosage (OSD) forms, particularly tablets manufactured by direct compression, offering improved flowability, compressibility, and content uniformity.

Starlose, a co-processed excipient offers excellent compressibility and good powder flow, resulting in tablets with optimal hardness, low friability, and reliable disintegration. This makes it well suited for immediate-release oral solids.

The starch excipient contributes to rapid disintegration, while the lactose monohydrate excipient supports good compressibility and palatability, providing balanced performance within a single excipient system.

Starlose excipient is suitable for a wide range of pharmaceutical oral solid dosage (OSD) forms, including immediate-release tablets, chewable tablets, capsules, and nutraceutical formulations.

Starlose, a co-processed excipient, performs well in both low-dose and high-dose pharmaceutical formulations where uniformity and processing efficiency are critical.

Starlose from Gangwal Healthcare is a co-processed excipient made from lactose monohydrate excipient and maize starch excipient that delivers improved tablet hardness, superior flowability, and faster disintegration in direct compression formulations.

Starlose excipient is manufactured under stringent GMP and regulatory compliant conditions ensuring consistent quality and performance. Backed by Gangwal Healthcare’s expertise in pharmaceutical excipients and co-processed excipients, Starlose supports efficient manufacturing in oral solid dosage (OSD) formulations.